Unannounced · 461 daysFiled 13 June 2025
AltrixBio, Inc. has sold $6.63M so far
AltrixBio, Inc., a pharmaceuticals company based in Wilmington, DE, has sold $6.63M so far in its convertible round, according to a filing dated 13 June 2025.
No public announcement found as of 16 September 2026, 461 days after the filing.
- Filed
- 13 June 2025
- Round
- Convertible round (amended filing)
- Amount sold
- $6.63M
- Offering size
- $6.63M
- Investors so far
- 50
- Based in
- Wilmington, DE
- Website
- altrixbio.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 47% of the 1,404 tracked raises with an amount filed in 2025.
AltrixBio, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 16 Jun 2025 | New filing | $1.15M | Another raise |
| 13 Jun 2025 | Amended filing | $6.63M | This raise |
| 13 Jun 2025 | New filing | $1.15M | This raise |
More with Point 406 Ventures on the board
- Ascellus Health, Inc.$2.06M
- Diana Health, Inc.$55.4M
- On Belay Holdings, Inc.$9.4M
- Heartbeat Health, Inc.$24M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.